Angela Shiratsu Yamada1, Flavia Tasmim Techera Antunes2, Camila Ferraz3, Alessandra Hubner de Souza4, Daniel Simon2,3. 1. Molecular and Cellular Biology Applied to Health, Lutheran University of Brazil (ULBRA), Canoas, Brazil. angelasyamada@gmail.com. 2. Molecular and Cellular Biology Applied to Health, Lutheran University of Brazil (ULBRA), Canoas, Brazil. 3. Human Molecular Genetics Laboratory, Lutheran University of Brazil (ULBRA), Canoas, Brazil. 4. Biochemical and Molecular Pharmacology from the Federal University of Minas Gerais, Belo Horizonte, Brazil.
Abstract
BACKGROUND: The Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene is a potential biomarker of vulnerability to pain. Thus, the present study aimed to investigate the association of this polymorphism with clinical and biopsychosocial factors in patients with chronic low back pain (CLBP). METHODS: A total of 107 individuals with CLBP answered questionnaires that were validated and adapted for the Brazilian population, including the Brief Inventory of Pain, the Central Sensitization Inventory, the Roland Morris Disability Questionnaire, the Tampa Scale for Kinesiophobia, the Pain Catastrophizing Scale, the Survey of Pain Attitude-Brief, and the Hospital Anxiety and Depression Scale. All of the subjects were genotyped for the BDNF Val66Met polymorphism. RESULTS: The sample showed moderate scores of disability, central sensitization, and kinesiophobia, in addition to mild anxiety, hopelessness, and ruminant thoughts. No significant association was observed between the Val66Met polymorphism and the variables analyzed. Besides, there was no relationship between the BDNF Val66Met polymorphism with CSI, catastrophization, or disabilities that were generated by CLBP. CONCLUSION: The results showed that the Val66Met polymorphism of the BDNF gene was not associated with clinical and biopsychosocial characteristics of CLBP in the sample studied.
BACKGROUND: The Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene is a potential biomarker of vulnerability to pain. Thus, the present study aimed to investigate the association of this polymorphism with clinical and biopsychosocial factors in patients with chronic low back pain (CLBP). METHODS: A total of 107 individuals with CLBP answered questionnaires that were validated and adapted for the Brazilian population, including the Brief Inventory of Pain, the Central Sensitization Inventory, the Roland Morris Disability Questionnaire, the Tampa Scale for Kinesiophobia, the Pain Catastrophizing Scale, the Survey of Pain Attitude-Brief, and the Hospital Anxiety and Depression Scale. All of the subjects were genotyped for the BDNF Val66Met polymorphism. RESULTS: The sample showed moderate scores of disability, central sensitization, and kinesiophobia, in addition to mild anxiety, hopelessness, and ruminant thoughts. No significant association was observed between the Val66Met polymorphism and the variables analyzed. Besides, there was no relationship between the BDNF Val66Met polymorphism with CSI, catastrophization, or disabilities that were generated by CLBP. CONCLUSION: The results showed that the Val66Met polymorphism of the BDNF gene was not associated with clinical and biopsychosocial characteristics of CLBP in the sample studied.
Entities:
Keywords:
BDNF; Catastrophizing; Central sensitization; Polymorphism; Single nucleotide polymorphism; Val66Met
Authors: Yuanyuan Tian; Xiaodong Liu; Mingzhong Jia; Hui Yu; Peter Lichtner; Yujian Shi; Zhaoyu Meng; Shanglong Kou; Idy H T Ho; Bo Jia; Benny C P Cheng; Carmen K M Lam; Sharon Tsang; Sunny H Wong; Jun Yu; Christopher H K Cheng; Tony Gin; William K K Wu; Zheyu Chen; Matthew T V Chan Journal: Anesthesiology Date: 2018-03 Impact factor: 7.892
Authors: Annette Becker; Heiko Held; Marcus Redaelli; Konstantin Strauch; Jean F Chenot; Corinna Leonhardt; Stefan Keller; Erika Baum; Michael Pfingsten; Jan Hildebrandt; Heinz-Dieter Basler; Michael M Kochen; Norbert Donner-Banzhoff Journal: Spine (Phila Pa 1976) Date: 2010-08-15 Impact factor: 3.468
Authors: Karine A Ferreira; Manoel Jacobsen Teixeira; Tito R Mendonza; Charles S Cleeland Journal: Support Care Cancer Date: 2010-03-10 Impact factor: 3.603
Authors: Ahmad Omair; Anne F Mannion; Marit Holden; Jeremy Fairbank; Benedicte A Lie; Olle Hägg; Peter Fritzell; Jens I Brox Journal: Eur Spine J Date: 2015-03-14 Impact factor: 3.134
Authors: Ellen Generaal; Yuri Milaneschi; Rick Jansen; Bernet M Elzinga; Joost Dekker; Brenda W J H Penninx Journal: Mol Pain Date: 2016-05-04 Impact factor: 3.395